Associated Papers
Unraveling the mysteries of Hutchinson-Gilford progeria syndrome: a comprehensive review of LMNA gene mutations.
Zhou X et al.
Biogerontology, 2025
Genetics and cancer-related Laminopathies: Involvement of Lamins and Lamin-Chromatin Interactions.
Desgrouas C et al.
Sub-cellular Biochemistry, 2025
Epidemiological characteristics of patients with Hutchinson-Gilford progeria syndrome and progeroid laminopathies in China.
Wang J et al.
Pediatric Research, 2024
Hutchinson-Gilford progeria syndrome complicated with stroke: A report of 2 cases and literature review.
Wang J et al.
Frontiers in Pediatrics, 2022
A targeted antisense therapeutic approach for Hutchinson-Gilford progeria syndrome.
Erdos MR et al.
Nature Medicine, 2021
Pharmacotherapy to gene editing: potential therapeutic approaches for Hutchinson-Gilford progeria syndrome.
Saxena S et al.
Geroscience, 2020
MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation.
Harhouri K et al.
Embo Molecular Medicine, 2017
28674081 (PubMed )
Supplement: EMMM-9-1294-s006.pdf
Antisense-Based Progerin Downregulation in HGPS-Like Patients' Cells.
Harhouri K et al.
Cells, 2016
Hutchinson-Gilford progeria syndrome.
Ullrich NJ et al.
Handbook of Clinical Neurology, 2015
Coronary artery disease in a Werner syndrome-like form of progeria characterized by low levels of progerin, a splice variant of lamin A.
Hisama FM et al.
American Journal of Medical Genetics. Part A, 2011
Select a paper to view details